NEJM Evidence Under Review: What the Status Can and Cannot Tell You

The public status does not provide a one-to-one map to internal work. Treat these as possible workflow interpretations, not asserted facts about your manuscript:

The journal's name matters here. NEJM Evidence is organized around evidence that can inform clinical research and health decisions. A reviewer may therefore test design, prespecification, outcome hierarchy, statistical interpretation, missing data, sensitivity analyses, and decision relevance as one connected chain. That is a preparation implication, not a claim that a particular reviewer has been assigned.

The duration column is deliberately bounded. NEJM Evidence does not publish a public status-to-duration dictionary that reveals the internal state of one submission.

These intervals are an author-work plan, not reported NEJM Evidence service levels. A manuscript-specific message always overrides the generic sequence.

Read the map as four checkpoints: Day 0: save the receipt and files. Days 1-7: answer any author request. Weeks 2-6: prepare the evidence chain without inferring sentiment. Week 7: compare the record with any expectation supplied for this manuscript before considering one inquiry.

Days 1-7: author-side checks

Confirm files, declarations, correspondence, and any open author task. These checks can happen while the journal's editorial work continues; they are not evidence that a reviewer has or has not been recruited.

Days 2-7: journal-side work may run in parallel

Administrative resolution, editorial routing, specialist matching, and preparation for reviewer recruitment can overlap. The range is a planning window for checking the record, not a reported NEJM Evidence turnaround target.

An NEJM Evidence handling editor is evaluating whether design, prespecification, effect estimates, uncertainty, reporting, and decision relevance form one defensible record. That work can require clinical and methodological expertise even while the public label remains unchanged. Authors cannot infer the editor's private judgment from that label, but they can prepare the paper's evidence chain: protocol, methods, primary result, uncertainty, limitations, and the claimed clinical consequence should remain consistent when read in sequence. This is a preparation framework, not a report about a private NEJM Evidence decision.

The rows are specific to an NEJM Evidence preparation job: align the protocol, use the applicable CONSORT or STROBE guidance in context, and make the clinical-decision boundary visible rather than guessing what an unseen reviewer prefers.

Use the reporting guideline that matches the design and cite its primary source in the response: CONSORT for randomized trials, STROBE for observational studies, PRISMA for systematic reviews, or the relevant EQUATOR-listed guidance. This is preparation advice, not a statement that a specific checklist has been requested.

“Does a long Under Review status mean the reviewers dislike the paper?”

No. The label exposes neither the number of accepted invitations nor the direction of any report. A long interval can reflect recruitment, specialist matching, replacement, active review, or synthesis. Preserve the dated record, prepare the evidence chain, and use the official channel only when a stated expectation is materially exceeded.

The label alone cannot answer that question because the public record does not expose reviewer invitations, accepted assignments, completed reports, or editorial synthesis. Compare the last dated event with a timeline supplied for this manuscript, confirm that no author task remains, and use the waiting period to prepare the evidence chain. If no journal-specific expectation exists, the planning map above is a work schedule, not a promise or a hidden verdict.

Use this sequence instead of a universal day count. Start with the dated manuscript record, then separate anything the authors still owe from time controlled by the journal. The right next action depends on that evidence: wait when the record is recent and complete, prepare materials that would shorten a revision, or ask once when the delay is materially unusual.

Wait when the record is recent and complete

Wait when the last transition is recent, the journal has supplied an expectation that has not been exceeded, and no author task is outstanding. Repeated inquiries do not reveal reviewer sentiment and can create extra administrative work. Save the date and set one deliberate check rather than refreshing the portal continuously.

Prepare when the paper is in the journal's hands

The waiting period is useful when preparation is tied to the paper's actual evidence. Build a one-page map with the central claim, its supporting figure or table, the relevant methods and protocol location, the uncertainty statement, and the strongest limitation. Then list the two objections that would most change the conclusion.

For a trial or intervention study, check whether the registered and reported outcomes agree. For an observational study, examine confounding, missingness, sensitivity analysis, and the language used for causal interpretation. For a diagnostic or prediction paper, check the evaluation population, calibration, discrimination, clinical-use comparison, and external validation. These tasks help under revision, rejection with comments, or transfer without assuming which decision will arrive.

Ask when the delay is materially atypical

Use the journal's manuscript-specific message or stated expectation when one exists. If the record is materially beyond that point, has not changed, and contains no unresolved author task, one neutral inquiry is reasonable. Include the manuscript ID, title, submission date, last visible transition, and a single operational question.

Subject: Status inquiry for NEJM Evidence manuscript [ID]

Dear Editorial Office, I am writing about manuscript MANUSCRIPT ID, “MANUSCRIPT TITLE,” submitted on SUBMISSION DATE. The latest visible status is Under Review, last updated on STATUS DATE. Could you please let us know whether the journal needs any information or action from the authors? Thank you for your time.

Do not ask whether the reviewers are positive, demand a decision date, or send parallel messages to multiple editors. If the office replies that review is continuing, return to the evidence record and wait for the next confirmed event.

Follow up only when the latest journal message or manuscript-specific expectation has been materially exceeded, the portal has not moved, and no author task remains unresolved. Send one inquiry through the manuscript record. If no expectation was provided, the week-by-week map above is a reminder to inspect evidence, not a guaranteed escalation clock.

In our source comparison and manuscript-readiness review, the most useful NEJM Evidence preparation artifact is a claim-to-decision map. It forces a team to show where the manuscript moves from design to evidence to a bounded consequence.

Three failure modes are worth resolving before a decision letter arrives.

Outcome drift: The abstract elevates an exploratory or secondary result while the protocol identifies another primary question. Prepare a clear reconciliation and revise only if the journal requests a new version.

Uncertainty buried in the supplement: The headline result is prominent, but missing-data assumptions, confidence intervals, sensitivity analyses, or subgroup limitations are difficult to find. Make a location map now so a response can point to the evidence precisely.

Decision claim outruns design: The discussion implies a practice or policy change that the population, comparator, follow-up, or design cannot establish. Draft a bounded alternative sentence before the reviewer identifies the mismatch.

This work is different from rewriting the manuscript speculatively. Do not submit an unsolicited replacement file or make a new submission elsewhere while the paper remains under consideration. The goal is to shorten and improve the eventual response using work that remains valuable across plausible outcomes.

A clean status decision has three columns:

This separation prevents two common mistakes. The first is treating a long wait as hidden rejection. The second is treating a rapid move to Under Review as proof of external review or enthusiasm. Both stories exceed the available evidence.

It also keeps advice current. Private workflow labels and journal systems can change. The durable behavior is to preserve the record, respond to author tasks, prepare the evidence chain, and use the official channel for a bounded inquiry.

None of these conditions reveals the likely editorial outcome. They convert limited status evidence into a proportionate author action.

The official manuscript record controls the private status. This guide helps you choose a proportionate next action without pretending that a public label reveals the decision.